Key result
Use of a blood pressure autoregulation system to maintain mean arterial pressure around 60 mmHg during major surgery decreased blood loss without unwanted clinical or laboratory effects.
Why the study?
Does a blood pressure autoregulation system safely maintain mean arterial pressure around 60 mmHg and reduce blood loss in patients undergoing major surgery?
Does a blood pressure autoregulation system safely maintain mean arterial pressure around 60 mmHg and reduce blood loss in patients undergoing major surgery?
A fuzzy logic-based blood pressure autoregulation system safely and effectively maintains hypotensive anesthesia to reduce blood loss during major surgery.
May support testing autoregulation for intraoperative hypotension; leaves open confirmation of safety and efficacy in trials.
A blood pressure autoregulation system based on the state-predictive control method was developed to minimize intraoperative blood loss and hence avoid blood transfusion. In this report, the system is further improved by incorporating fuzzy logic with a fail-safe function and an individual parameter-identifying function. The safety and stability of this system had been confirmed by preclinical experiments with dogs. Thereafter clinical application with 17 patients was conducted to maintain their mean arterial pressure at around 60 mmHg during major surgery. The use of this system resulted in decreased blood loss and more speedy and accurate surgery due to a clearer surgical field. Unwanted effects of hypotension were not observed clinically or in laboratory tests. This system is therefore safe, stable, and effective in reducing the blood loss during major surgery that otherwise might cause substantial blood loss.
No takes yet. Share an insight, caveat, or question.
Onodera et al. (1999) studied Major surgery (n=17). Blood pressure autoregulation system was evaluated on Blood loss and safety. Use of a blood pressure autoregulation system to maintain mean arterial pressure around 60 mmHg during major surgery decreased blood loss without unwanted clinical or laboratory effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: